LPL Financial’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
LPL Financial's GNOM Position: Q3 2026 in Review
LPL Financial increased its Global X Genomics & Biotechnology ETF (GNOM) stake by 28% in Q3 2026, buying an estimated $639K and bringing the position to 48,074 shares worth $3.39M. The position accounts for ﹤0.01% of the portfolio, ranked #3234.
LPL Financial first reported a position in GNOM in Q4 2020 and has held it in 24 quarters since. 51 funds tracked by Wall St. Rank hold GNOM as of Q3 2026.
- LPL Financial held 48,074 shares of Global X Genomics & Biotechnology ETF worth $3.39M as of Q3 2026.
- LPL Financial bought 10,475 Global X Genomics & Biotechnology ETF shares in Q3 2026, an estimated $639K.
- Global X Genomics & Biotechnology ETF made up ﹤0.01% of LPL Financial's portfolio in Q3 2026, its #3234 holding.
- LPL Financial first reported a position in Global X Genomics & Biotechnology ETF in Q4 2020 and has held it in 24 quarters since.
- 51 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q3 2026.
Based on LPL Financial's 13F filing for Q3 2026, filed 6 Nov 2026.